Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
6.77
0.19 (2.89%)
At close: Jun 05, 2025, 3:59 PM
6.98
3.12%
After-hours: Jun 05, 2025, 07:47 PM EDT
2.89%
Bid 6.72
Market Cap 688.81M
Revenue (ttm) n/a
Net Income (ttm) -47.35M
EPS (ttm) -0.45
PE Ratio (ttm) -15.04
Forward PE -11.76
Analyst Buy
Ask 6.98
Volume 2,354,999
Avg. Volume (20D) 2,630,639
Open 6.46
Previous Close 6.58
Day's Range 6.35 - 6.90
52-Week Range 2.30 - 7.48
Beta 0.53

About TRVI

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRVI
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TRVI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 days ago
-5.85%
Trevi Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
4 days ago
-2.92%
TRVI stock has given up its prior gain. Trevi Therapeutics shares were trading higher after the company announced positive topline results from its Phase 2b CORAL trial of Haduvio.